247 related articles for article (PubMed ID: 22002331)
1. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
[TBL] [Abstract][Full Text] [Related]
2. Sacrococcygeal chordoma with a malignant spindle cell component. A report of two autopsy cases with a review of the literature.
Fukuda T; Aihara T; Ban S; Nakajima T; Machinami R
Acta Pathol Jpn; 1992 Jun; 42(6):448-53. PubMed ID: 1502905
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) status in chordoma.
Ptaszyński K; Szumera-Ciećkiewicz A; Owczarek J; Mrozkowiak A; Pekul M; Barańska J; Rutkowski P
Pol J Pathol; 2009; 60(2):81-7. PubMed ID: 19886182
[TBL] [Abstract][Full Text] [Related]
4. Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma.
Deshpande V; Nielsen GP; Rosenthal DI; Rosenberg AE
Am J Surg Pathol; 2007 Oct; 31(10):1573-7. PubMed ID: 17895760
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a novel chordoma cell line: CH22.
Liu X; Nielsen GP; Rosenberg AE; Waterman PR; Yang W; Choy E; Sassi S; Yang S; Harmon DC; Yang C; Schwab JH; Kobayashi E; Mankin HJ; Xavier R; Weissleder R; Duan Z; Hornicek FJ
J Orthop Res; 2012 Oct; 30(10):1666-73. PubMed ID: 22504929
[TBL] [Abstract][Full Text] [Related]
6. First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions.
Yamaguchi T; Yamato M; Saotome K
Skeletal Radiol; 2002 Jul; 31(7):413-8. PubMed ID: 12107574
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration of a chordoma and its recurrence 19 years after.
Saiz A; de Agustín P; Barrios AP; Alberti N
Diagn Cytopathol; 2006 Sep; 34(9):663-4. PubMed ID: 16900473
[No Abstract] [Full Text] [Related]
8. Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.
von Witzleben A; Goerttler LT; Marienfeld R; Barth H; Lechel A; Mellert K; Böhm M; Kornmann M; Mayer-Steinacker R; von Baer A; Schultheiss M; Flanagan AM; Möller P; Brüderlein S; Barth TF
Cancer Res; 2015 Sep; 75(18):3823-31. PubMed ID: 26183925
[TBL] [Abstract][Full Text] [Related]
9. Total resection of inferiorly located sacral chordoma with posterior only approach: case report and review of the literature.
Sabuncuoglu H; Ozdogan S; Dogan H; Ataoglu O; Tımurkaynak E
Turk Neurosurg; 2010 Oct; 20(4):527-32. PubMed ID: 20963705
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
[TBL] [Abstract][Full Text] [Related]
11. [Sacrococcygeal chordoma with malignant spindle cell components. Case report and review of the literature].
Woenckhaus J; Benedix P; Holotiuk O; Riedel H; Justus J
Pathologe; 1997 Sep; 18(5):395-400. PubMed ID: 9432676
[TBL] [Abstract][Full Text] [Related]
12. Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein.
Ostroumov E; Hunter CJ
Spine (Phila Pa 1976); 2008 Dec; 33(25):2774-80. PubMed ID: 19050584
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
Kim JY; Lee J; Koh JS; Park MJ; Chang UK
J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
[TBL] [Abstract][Full Text] [Related]
15. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
[TBL] [Abstract][Full Text] [Related]
16. [Sacrococcygeal chordoma. Results of radical operation].
Rosell Pradas J; Ruiz Morales M; Guerrero Fernández JA; Vara-Thorbeck R
Zentralbl Chir; 1991; 116(21):1253-7. PubMed ID: 1796661
[No Abstract] [Full Text] [Related]
17. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.
Owen JH; Komarck CM; Wang AC; Abuzeid WM; Keep RF; McKean EL; Sullivan S; Fan X; Prince MEP
J Neurosurg; 2018 Mar; 128(3):701-709. PubMed ID: 28430034
[TBL] [Abstract][Full Text] [Related]
18. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
[TBL] [Abstract][Full Text] [Related]
19. Hand metastasis from a sacral chordoma.
Emori M; Kaya M; Sugita S; Soma T; Sasaki M; Yamashita T
Ann R Coll Surg Engl; 2014 Nov; 96(8):e8-11. PubMed ID: 25350167
[TBL] [Abstract][Full Text] [Related]
20. Sacral chordoma: a diagnosis not to be sat on?
Jeys L; Gibbins R; Evans G; Grimer R
Int Orthop; 2008 Apr; 32(2):269-72. PubMed ID: 17205349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
